表紙

Contents

Japanese

Ⅰ. 「医療用医薬品の流通改善に向けて流通関係者が遵守すべきガイドライン」の改訂

1. ガイドライン改訂の経緯

2. 本改訂案の内容

Ⅱ. 「医療従事者の困りごと調査を踏まえた難病・希少疾患に関する提言」の公表

1. 疾患啓発および患者への情報提供に関する課題と提言

2. 早期診断体制強化に関する課題と提言

3. 研究開発加速に関する課題と提言

4. その他の課題と提言

English

1. Revision of the “Guidelines to Be Observed by Distribution-Related Parties for the Improvement of Distribution of Prescription Drugs”

1.1 Background to the Revision of the Guidelines

1.2 Contents of the Draft Revision

2. Publication of the “Recommendations on Intractable and Rare Diseases Based on a Survey of Challenges Faced by Healthcare Professionals”

2.1 Issues and Recommendations Regarding Disease Awareness and Information Provision to Patients

2.2 Issues and Recommendations Regarding Strengthening Early Diagnosis Systems

2.3 Issues and Recommendations Regarding Accelerating Research and Development

2.4 Other Issues and Recommendations

奥付